Menu Search
Equities

Ion Beam Applications SA

IBAB:BRU

Ion Beam Applications SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)13.54
  • Today's Change0.34 / 2.58%
  • Shares traded9.40k
  • 1 Year change+20.46%
  • Beta0.9652
Data delayed at least 15 minutes, as of Nov 22 2024 10:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 22-Nov-24
Select bar for recommendation details.
Recommendations22-Nov-24
Buy1
Outperform1
Hold2
Sell0
Strong Sell0

Share price forecast in EUR

The 4 analysts offering 12 month price targets for Ion Beam Applications SA have a median target of 16.30, with a high estimate of 21.40 and a low estimate of 14.00. The median estimate represents a 23.48% increase from the last price of 13.20.
High62.1%21.40
Med23.5%16.30
Low6.1%14.00

Dividends in EUR

In 2023, Ion Beam Applications SA reported a dividend of 0.12 EUR, which represents a 19.05% decrease from last year. The 3 analysts covering the company expect dividends of 0.17 EUR for the upcoming fiscal year, an increase of 42.86%.
Div growth (TTM)-19.05%
More ▼

Earnings history & estimates in EUR

Ion Beam Applications SA reported annual 2023 losses of -0.31 per share on Mar 21, 2024.
Average growth rate+92.51%
More ▼

Revenue history & estimates in EUR

Ion Beam Applications SA had revenues for the full year 2023 of 428.72m. This was 18.67% above the prior year's results.
Average growth rate+17.71%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.